Former CEO of evitria AG (2020-2023)
Mail: ce@evitria.com
Christian Eberle is a member of the Board of Directors of evitria’s parent company Atlas Antibodies and former CEO of evitria AG. He has led evitria AG through its growth trajectory from 2020 to 2023.
With both a Master’s degree in chemistry and a PhD in medicinal and pharmaceutical chemistry from ETH Zurich, he has brought profound expert knowledge into the operational level of biotechnology companies.
In the course of his career, Christian Eberle has accumulated broad experience in business strategy as well as in research, development and manufacturing within the pharmaceutical and biotechnology industry, but also in CDMO companies.
LinkedIn profile: Christian Eberle
Articles
Recombinant antibody production is vital in drug development as well as for therapeutic and research purposes. In this article, we will discuss methods and benefits of recombinant antibody production.
Antibody sequencing is a complex procedure, where dedicated service providers often come into place. In this article, we will give you more information on antibody sequencing services.
Polyclonal antibodies are valuable tools in life sciences. But what are they, exactly? In this article, we provide an answer to this question.